Ignite Creation Date:
2024-05-06 @ 3:50 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02389244
Status:
RECRUITING
Last Update Posted:
2023-11-07
First Post:
2015-02-09
Brief Title:
A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
Sponsor:
UNICANCER
Organization:
UNICANCER
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ewing Sarcomas |
| Chondrosarcomas |
| Osteosarcomas |
| Chondroma |
| CIC-Rearranged Sarcoma |
Keywords: